Organic Letters
Letter
pated in the C−H methylation reaction at 80 °C to exclusively
provide 3c in 74% yield. Complete site selectivity at the more
electrophilic C1-position was observed. This reaction was also
compatible with quinoxaline N-oxide (1d), a structural isostere
of 1b, delivering 3d in 80% yield. In the case of the sterically
congested 3,5-disubstituted pyrazine N-oxide, C2-selective
methylation of 1e occurred, presumably due to both steric and
electronic effects, and 60% of the starting material 1e was
recovered. Additionally, 5,6-benzoquinoline N-oxide (1f)
successfully reacted with 2a, furnishing the redox-neutral adduct
3f (76%) and reductive adduct 3fa (4%). In the case of 4-methyl
quinoline N-oxide (1g), a 2:1 ratio between 3g and 3ga was
observed. The reaction of 3,4-benzoquinoline N-oxide (1h)
provided the almost identical amount of redox-neutral product
3h (46%) and reductive adduct 3ha (46%). The incomplete
chemoselectivity for 3h could be rationalized by the competitive
aromatization over E2-elimination of the betaine intermediate.
Moreover, halogen substituents in 1i and 1j were tolerated
under the current reaction conditions. To our delight, C8-
substituted quinoline N-oxides 1k and 1l also underwent site-
selective and redox-neutral methylation reactions to give the
corresponding products. Surprisingly, unprotected 8-amino and
8-hydroxyl quinoline N-oxides 1m and 1n were found to be
good substrates for this transformation. Note that 8-amino-
quinoline is a pivotal core found in biologically relevant
molecules and bidentate ligands.13 Therefore, our developed
method would encourage organic and medicinal chemists to
attempt the C2-functionalization of 8-aminoquinoline deriva-
tives for preparing valuable medicinal and industrial compounds.
Having demonstrated the scope of heterocyclic N-oxides, we
performed the reaction of quinoxaline N-oxide (1d) with
diphenyl cyclopropylsulfonium salt 2b (Scheme 3). We were
Scheme 4. Late-Stage C−H Methylations of Bioactive
Molecules
Scheme 5. Sequential Transformation Using Hydroquinidine
Scheme 3. Cyclopropylation of Quinoxaline N-Oxide
methylation. The Boekelheide rearrangement14 of 6c afforded
the reductive C2-methylated hydroquinidine derivative 6d in
70% yield. These results can serve as a guide for the tentative
derivatization of quinine-based antimalarial and antiarrhythmic
agents in drug discovery.
Next, we carried out a series of transformations to
functionalize the benzylic and C8−C−H bonds of the
synthesized C2-methylated quinoline N-oxide 3b assisted by
an N-oxide group (Scheme 6). The reaction of 3b with 7a
derived from NSAID celecoxib under basic conditions resulted
in the formation of 8a (70%) via nucleophilic addition and a
subsequent dehydration reaction (eq 1). The Rh(III)-catalyzed
C−H arylation and Pd(II)-catalyzed C−H acylation of 3b with
diazo compound 7b and α-keto acid 7c afforded 8b (95%) and
8c (65%), respectively (eqs 2 and 3). The 8-aminated quinoline
adduct 3l was also obtained in 94% yield by the Ir(III)-catalyzed
C−H amination reaction,15 which can be an alternative route for
the synthesis of 8-aminoquinolines (eq 4).
To gain mechanistic insights into this transformation, we
performed the reaction of deuterium-labeled quinoline N-oxide
(deuterio-1b) with 2a under the standard reaction conditions
(Scheme 7). No deuterium incorporation at the benzylic
position was observed, suggesting that the intramolecular
deuterium 1,2-migration in the reaction pathway is completely
excluded (eq 1). To recognize the fate of sulfonium salts, we
performed the reaction of 1d with 1 equiv of 2b. Product 3o and
diphenyl sulfide 9a were obtained in almost identical yields,
pleased to observe the formation of cyclopropylated quinoxaline
N-oxide 3o in 91% yield. A trace amount of reductive C2-
cyclopropylated product 3oa was observed. However, linear
alkylsulfonium salts such as Et3SCl, EtPh2SBF4, and (n-Bu)3SI
were unreactive under the current reaction conditions.
The applicability of the developed protocol is highlighted by
the late-stage C−H methylation reaction of biologically
important N-heterocyclic molecules, as shown in Scheme 4.
For example, the antiarrhythmic O-methylated quinidine N-
oxide (4a) was readily methylated by using increased amounts
(5 equiv) of KOtBu, pyrrolidine, and 2a to afford 5a in 94% yield
(eq 1). It is noted that the reaction provided 5a in 42% yield and
starting material 4a in 46% yield under the standard reaction
conditions. In addition, a fasudil derivative as a RhoA/Rho
kinase inhibitor smoothly reacted with 2a to give the desired
product 5b in 77% yield (eq 2).
Subsequently, we performed the sequential transformation of
hydroquinidine (6a) to demonstrate the utility of the developed
method (Scheme 5). Treatment of 6a with m-CPBA followed by
the reduction of quinuclidine N-oxide furnished 6b in 90%
overall yield. The gram-scale methylation reaction of hydro-
quinidine N-oxide (6b) provided 6c in 92% yield. Interestingly,
the reaction resulted in both C2-methylation and O-
C
Org. Lett. XXXX, XXX, XXX−XXX